IgeaHub gives professionals, patients and investors interested in pharmaceuticals, biotechnology, health economics, diagnostics and medical devices the most relevant, actionable news, information and analysis available anywhere. Our goal is to provide expert insights, analysis and information from industry leaders with a deep understanding of life sciences, medicine and healthcare. Created and curated by Luca Dezzani, MD, Global Brand Medical Director at Novartis Oncology*, IgeaHub offers an insider’s view on the most important developments in life sciences, healthcare technology, digital health and more.

When you come to IgeaHub.com, you will find news and updates on critical topics that include, but are not limited to

Pharmaceutical and biotechnology research and development

Pharmaceutical manufacturing

Pharmaceutical marketing and sales

Pharmaceutical jobs and career

Diagnostics and personalized medicine

Clinical trials

Biotech investment

Health policy

Medical devices

Digital health

Access to medicines

Reimbursement

Health economics

Intellectual property and patent protection

Patient advocacy

 

The most timely and relevant information, analysis and insights into these key areas will help medical professionals, industry executives, researchers and patients better understand these changes and make decisions that can contribute to better health outcomes and quality of life for themselves, their industry and their families. Igeahub is the pharmaceutical blog that will provide this information.

IgeaHub will also regularly include guest posts from other industry experts. We invite those who are interested in contributing to IgeaHub to please get in touch. Let us know your areas of interest, and please include a short bio or a link to your LinkedIn profile.

We look forward to becoming your trusted partner.

 

IgeaHub is a pharmaceutical blog created and curated by Luca Dezzani.  Luca is physician who works as Global Brand Medical Director at Novartis Oncology. IgeaHub is a source of information about medicine, healthcare, and pharmaceutical industry. All the views, analysis, and perspectives are fully independent and belongs to the authors only. They do not represent the views or opinions of Novartis or any other company or organization.

All the contents come from publicly available sources and articles are usually factual, objective, and properly referenced. No confidential information or embargoed data can be found on the website. IgeaHub does not receive any founding or support from Novartis or any other pharmaceutical company. All the activities required for the conduction and maintenance of the blog are carried out during free time and using independent resources. All content are created for informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. IgeaHub  does not recommend or endorse any specific tests, physicians, products, procedures, or other information that may be mentioned on the website. Although every attempt is made to ensure the accuracy and reliability of the information provided, no warranty expressed or implied is made regarding accuracy, adequacy, completeness, legality, reliability or usefulness of any information. The same principles apply to contents shared or published on any other social media.